Among the imported cases from Morocco, 11 hospitalizations were reported in January 2025, highlighting the seriousness of the situation.

Currently, around 100 active measles cases have been reported across France, a significant rise compared to the COVID-19 lockdown period when cases dropped to just 15 in both 2021 and 2022.

While measles typically resolves within ten days, complications can arise in about 30% of cases, ranging from mild issues like ear infections to severe conditions such as pneumonia.

The French Health Ministry is urging healthcare professionals to remain vigilant due to a recent surge in measles cases, particularly linked to imported cases from Morocco.

Initial symptoms of measles include a high fever, runny nose, cough, and conjunctivitis, lasting approximately three to four days.

Infants, pregnant women, and immunocompromised individuals are at a heightened risk for severe complications from measles.

A warning issued by the Directorate General of Health on March 7, 2025, highlights the extreme contagiousness of measles and anticipates an increase in cases in the coming weeks.

High vaccination coverage across all age groups, including healthcare professionals, is crucial to limit the spread of the virus and protect vulnerable populations.

The characteristic measles rash appears later, starting as small red spots on the face and spreading to the neck, torso, and limbs over a period of three days.

In France, measles vaccination has been mandatory since January 1, 2018, requiring doses at 12 and 16-18 months, and can be effective if administered within 72 hours of exposure.

In the southwestern United States, a measles outbreak has resulted in two deaths and nearly 230 infections, underscoring the ongoing risk of the disease.

Europe has seen a concerning rise in measles cases, with 32,265 reported between February 2024 and January 2025, largely due to low vaccination rates in countries like Romania.